Beyond-use dating of extemporaneously compounded ketamine, acepromazine, and xylazine: Safety, stability, and efficacy over time

Journal of the American Association for Laboratory Animal Science

Volumn 48, Issue 6, 2009, Pages 718-726

  Taylor, Brett J ^a   Orr, Steven A ^a   Chapman, Jennifer L ^a   Fisher, Diana E ^a  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEPROMAZINE; ACEPROMAZINE PLUS KETAMINE PLUS XYLAZINE; ANESTHETIC AGENT; KETAMINE; METHYL PARABEN; UNCLASSIFIED DRUG; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MIXTURE; DRUG SAFETY; DRUG STABILITY; FASCIITIS; HISTOPATHOLOGY; INFLAMMATION; MALE; MICROBIOLOGY; MOUSE; MYOSITIS; NONHUMAN; PARTICULATE MATTER; PH; RAT; REGRESSION ANALYSIS; RIGHTING REFLEX; ROOM TEMPERATURE;

ACEPROMAZINE; ANESTHESIA; ANESTHETICS, COMBINED; ANIMALS; BEHAVIOR, ANIMAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; KETAMINE; MALE; MICE; MICE, INBRED BALB C; ORIENTATION; PAIN MEASUREMENT; RATS; RATS, INBRED BN; REACTION TIME; TIME FACTORS; XYLAZINE;

ANIMALIA; MUS; RATTUS; RODENTIA;

EID: 74049092345     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. American Veterinary Medical Association. [Internet]. Brochure on veterinary compounding. [Cited 30 Mar 2009]. Available at http:// www.avma.org/issues/drugs/compounding/veterinary-com-pounding-brochure.asp.
2. Arras M, Autenried P, Rettich A, Spaeni D, Rulicke T. 2001. Optimization of intraperitoneal injection anesthesia in mice: drugs, dosages, adverse effects, and anesthesia depth. Comp Med 51:443-456. (Pubitemid 33097866)
3. Bui BV, Fortune B. 2004. Ganglion cell contributions to the rat full-field electroretinogram. J Physiol 555:153-173. (Pubitemid 38313068)
4. Buitrago S, Martin TE, Tetens-Woodring J, Belicha-Villanueva A, Wilding GE. 2008. Safety and efficacy of various combinations of injectable anesthetics in BALB/c mice. J Am Assoc Lab Anim Sci 47:11-17. (Pubitemid 351183365)
5. Cruz JI, Loste JM, Burzaco OH. 1998. Observations on the use of medetomidine-ketamine and its reversal with atipamezole for chemical restraint in the mouse. Lab Anim 32:18-22.
6. Danias J, Kontiola AI, Filippopoulos T, Mittag T. 2003. Method for the noninvasive measurement of intraocular pressure in mice. Invest Ophthalmol Vis Sci 44:1138-1141. (Pubitemid 36297832)
7. Davalos D, Lee JK, Smith WB, Brinkman B, Ellisman M, Zheng B, Akassoglou K. 2008. Stable in vivo imaging of densely populated glia, axons, and blood vessels in the mouse spinal cord using 2-photon microscopy J Neurosci Methods 169:1-7.
8. Davy CW, Trennery PN, Edmunds JG, Altman JFB, Eichler DA. 1987. Local myotoxicity of ketamine hydrochloride in the marmoset. Lab Anim 21:60-67.
9. Food and Drug Administration. [Internet]. Expiration dating of unit-dose repackaged drugs: compliance policy guide. Draft guidance, 2005. [Cited 30 Mar 2009]. Available at http://www.fda.gov/CDER/GUIDANCE/6169dft.pdf.
10. Gaertner DJ, Boschert KR, Shoeb TR. 1987. Muscle necrosis in Syrian hamsters resulting from intramuscular injections of ketamine and xylazine. Lab Anim Sci 37:80-83.
11. Gaertner DJ, Hallman TM, Hankenson FC, Batchelder MA. 2008. Anesthesia and analgesia for laboratory rodents, p 239-282. In: Fish RE, Brown MJ, Danneman PJ, Karas AZ, editors. Anesthesia and analgesia in laboratory animals. San Diego (CA): Academic Press.
12. Gardner DJ, Davis JA, Weina PJ, Theune B. 1995. Comparison of tribromoethanol, ketamine/acetylpromazine, Telazol/xylazine, pentobarbital, and methoxyflurane anesthesia in HSD:ICR mice. Lab Anim Sci 45:199-204.
13. Hawk CT, Leary SL. 1999. Formulary for laboratory animals, p 48. 2nd ed. Ames (IA): Iowa State University Press.
14. Hayashi H, Dikkes P, Soriano SG. 2002. Repeated administration of ketamine may lead to neuronal degeneration in the developing rat brain. Paediatr Anaesth 12:770-774. (Pubitemid 36051344)
15. Hobbs BA, Rolhall TG, Sprenkel TL, Anthony KL. 1991. Comparison of several combinations for anesthesia in rabbits. Am J Vet Res 52:669-674.
16. Holcombe DJ, Lengefeld N, Gole GA, Barnett NL. 2008. The effects of acute intraocular pressure elevation on rat retinal glutamate transport. Acta Opthalmol 86:408-414.
17. Huang CS, Boudinot FD, Feldman S. 1995. Effects of gender, pregnancy, and anesthesia on the pharmacokinetics of zidovudine in rats. Pharm Res 12:1647-1654.
18. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
19. International Organization for Standardization. 2006. Sterile hypodermic syringes for single use, part 1: syringes for manual use. ISO 7886-1:2006.
20. Kairuz TE, Gargiulo D, Bunt C, Garg S. 2007. Quality, safety, and efficacy in the 'off-label' use of medicines. Curr Drug Saf 2:89-95.
21. Keith K, Nicholson D, Rogers D. 2004. Accuracy and precision of a low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 43:69-74. (Pubitemid 38112268)
22. Koulchitsky SV. 1998. Are the capsaicin-sensitive structures of ventral medulla involved in the temperature response to endotoxin in rats? Neurosci Lett 244:112-114.
23. Lawson DM, Duke JL, Zammit TG, Collins HL, DiCarlo SE. 2001. Recovery from carotid artery catheterization performed under various anesthetics in male Sprague-Dawley rats. Contemp Top Lab Anim Sci 40:18-22.
24. Lipman NS, Marini RP, Erdman SE. 1990. A comparison of ketamine-xylazine and ketamine-xylazine-acepromazine anesthesia in the rabbit. Lab Anim Sci 40:395-398.
25. Lteif AN, Schwenk WF. 1999. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 22:137-140.
26. Mastronardi CA, Yu WH, McCann SM. 2001. Lipopolysaccharide-induced tumor necrosis factor-alpha is controlled by the central nervous system. Neuroimmunomodulation 9:148-156. (Pubitemid 34042867)
27. Nagaraju M, Saleh M, Porciatti V. 2007. IOP-dependent retinal ganglion cell dysfunction in glaucomatous DBA/2J mice. Invest Ophthalmol Vis Sci 48:4573-4579. (Pubitemid 351260974)
28. Prophet EB, Mills B, Arrington JB, Sobin LH; Armed Forces Institute of Pathology. 1992. Laboratory methods for histotechnology, p25-29. Washington (DC): American Registry of Pathology.
29. Raju JR, Weinberg DV. 2002. Accuracy and precision of intraocular injection volume. Am J Ophthalmol 133:564-566.
30. Roper SN, Gilmore RL, Houser CR. 1995. Experimentally induced disorders of neuronal migration produce an increased propensity for electrographic seizures in rats. Epilepsy Res 21:205-219.
31. Sato Y, Kobayashi E, Hakamata Y, Kobahashi M, Wainai T, Murayama T, Mishina M, Seo N. 2004. Chronopharmacological studies of ketamine in normal and NMDA ε1 receptor knockout mice. Br J Anaesth 92:859-864. (Pubitemid 38771689)
32. Scallet AC, Schmued LC, Slikker W, Grunberg N, Faustino PJ, Davis H, Lester D, Pine PS, Sistare F, Hanig JP. 2004. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci 81:364-370. (Pubitemid 39377966)
33. Smiler KL, Stein S, Hrapkiewicz KL, Hiben JR. 1990. Tissue response to intramuscular and intraperitoneal injections of ketamine and xylazine in rats. Lab Anim Sci 40:60-64. (Pubitemid 20061883)
34. Smith W. 1993. Responses of laboratory animals to some injectable anaesthetics. Lab Anim 27:30-39. (Pubitemid 23060209)
35. Society of Veterinary Hospital Pharmacists. [Internet]. Position statement on compounding of drugs for use in animals. [Cited 30 Mar 2009]. Available at http://www.svhp.org/Compounding-Statement.pdf.
36. Stabenow JM, Maske ML, Vogler GA. 2006. Refractometry for quality control of anesthetic drug mixtures. J Am Assoc Lab Anim Sci 45:60-63.
37. Steffen BT, Lees SJ, Booth FW. 2008. AntiTNF treatment reduces rat skeletal muscle wasting in monocrotaline-induced cardiac cachexia. J Appl Physiol 105:1950-1958.
38. Thompson JS, Brown SA, Khurdayan V, Zeynalzadedan A, Sullivan PG, Scheff SW. 2002. Early effects of tribromoethanol, ketamine/xylazine, pentobarbital, and isoflurane anesthesia on hepatic and lymphoid tissue in ICR mice. Comp Med 52:63-67. (Pubitemid 34226375)
39. United States Pharmacopeial Convention. USP 32. 2008. Baltimore (MD): United Book Press.
40. Vachon P. 1999. Self-mutilation in rabbits following intramuscular ketamine-xylazine-acepromazine injections. Can Vet J 40:581-582. (Pubitemid 29411125)
41. van Heeckeren AM, Schluchter MD. 2002. Murine models of chronic Pseudomonas aeruginosa lung infection. Lab Anim 36:291-312. (Pubitemid 34785765)
42. Vlach KD, Boles JW, Stiles BG. 2000. Telemetric evaluation of body temperature and physical activity as predictors of mortality in a murine model of staphylococcal enterotoxic shock. Comp Med 50:160-166.
43. Welberg LA, Kinkead B, Thrivikraman KV, Huerkamp MJ, Nemeroff CB, Plotsky PM. 2006. Ketamine-xylazine-acepromazine anesthesia and postoperative recovery in rats. J Am Assoc Lab Anim Sci 45:13-20. (Pubitemid 43835585)
44. Wood AK, Klide AM, Pickup S, Kundel HL. 2001. Prolonged general anesthesia in MR studies of rats. Acad Radiol 8:1136-1140. (Pubitemid 33032266)
45. Woodward WR, Choi D, Grose J, Malmin B, Hurst S, Pang J, Weleber RG, Pillers DM. 2007. Isoflurane is an effective alternative to ketamine-xylazine- acepromazine as an anesthetic agent for the mouse dectroretinogram. Doc Ophthalmol 115:187-201. (Pubitemid 350048140)